
Incidence of atrial fibrillation and its effects on long-term follow-up outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction
Author(s) -
Şükrü Arslan,
Servet Batıt,
Onur Kılıçarslan,
Ömer Tamer Doğan,
Mehmet Tugay Yumuk,
Şeyma Arslan,
İsmail Haberal,
Cüneyt Koçaş,
Sait Mesut Doğan,
Okay Abacı
Publication year - 2021
Publication title -
anatolian journal of cardiology
Language(s) - English
Resource type - Journals
eISSN - 2149-2271
DOI - 10.5152/anatoljcardiol.2021.26020
Subject(s) - medicine , conventional pci , percutaneous coronary intervention , cardiology , atrial fibrillation , myocardial infarction , incidence (geometry) , clinical endpoint , killip class , angioplasty , randomized controlled trial , physics , optics
The incidence of atrial fibrillation (AF) in patients with ST segment elevation myocardial infarction (STEMI) varies between 7% and 21%, and most of these studies were in the thrombolytic era. However, the frequency of new-onset AF during the primary percutaneous coronary intervention (PCI) period is still unclear. We aimed to investigate the frequency of new-onset AF and its effects on long-term clinical events in patients undergoing primary PCI.